Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy Journal Article


Authors: Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; Shah, G.; Perales, M. A.; Palomba, M. L.; Yahalom, J.
Article Title: Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
Abstract: Radiotherapy is potentially an important salvage strategy post-chimeric antigen receptor T cell therapy (CART), but limited data exist. We reviewed 14 patients treated with salvage radiation post-CART progression (SRT). Most received SRT for first post-CART relapse (71%) to sites previously PET-avid pre-CART (79%). Median overall survival (OS) post-SRT was 10 months. Post-SRT, six localized relapses achieved 100% response (3 = complete, 3 = partial), with improved freedom from subsequent relapse (P = 0·001) and OS (P = 0·004) compared to advanced stage relapses. Three were bridged to allogeneic transplantation; at analysis, all were alive/NED. SRT has diverse utility and can integrate with novel agents or transplantation to attempt durable remissions. © 2020 British Society for Haematology and John Wiley & Sons Ltd
Keywords: adult; cancer survival; controlled study; treatment outcome; aged; overall survival; clinical feature; salvage therapy; treatment duration; cancer radiotherapy; radiation dose; cancer staging; recurrence risk; clinical practice; radiotherapy; cohort analysis; retrospective study; nonhodgkin lymphoma; experience; remission; cd19 antigen; cell killing; relapsed/refractory; diffuse large b cell lymphoma; human; male; female; priority journal; article; car t cells; chimeric antigen receptor t cells; chimeric antigen receptor t-cell immunotherapy
Journal Title: British Journal of Haematology
Volume: 190
Issue: 1
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-07-01
Start Page: 45
End Page: 51
Language: English
DOI: 10.1111/bjh.16541
PUBMED: 32135029
PROVIDER: scopus
PMCID: PMC7329607
DOI/URL:
Notes: Article -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    625 Yahalom
  2. Renier J Brentjens
    286 Brentjens
  3. Maria Lia Palomba
    415 Palomba
  4. Sergio Andres Giralt
    1050 Giralt
  5. Jae Hong Park
    356 Park
  6. Craig Steven Sauter
    334 Sauter
  7. Miguel-Angel Perales
    913 Perales
  8. Michel W J Sadelain
    583 Sadelain
  9. Parastoo Bahrami Dahi
    294 Dahi
  10. Michael Scordo
    365 Scordo
  11. Connie Wing-Ching Lee Batlevi
    176 Batlevi
  12. Gunjan Lalitchandra Shah
    418 Shah
  13. Brandon Stuart Imber
    214 Imber